Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00910988
What this trial is testing

Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

Who this might be right for
HyperglycemiaHyperlipidemia
Washington University School of Medicine 46
Testing effectiveness (Phase 2)Study completedNCT04524403
What this trial is testing

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)
Corcept Therapeutics 150
Testing effectiveness (Phase 2)Study completedNCT00361166
What this trial is testing

Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone

Who this might be right for
Schizophrenia
ACADIA Pharmaceuticals Inc. 400
Not applicableStudy completedNCT01269710
What this trial is testing

Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+8 more
University of North Carolina, Chapel Hill 4
Not applicableStudy completedNCT00707382
What this trial is testing

Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment

Who this might be right for
Schizophrenia
Gesche Jurgens 311
Large-scale testing (Phase 3)Study completedNCT00034762
What this trial is testing

Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease

Who this might be right for
DementiaAlzheimer DiseaseMental Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Not applicableEnded earlyNCT00746252
What this trial is testing

Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder

Who this might be right for
Bipolar Disorder
University of Maryland, Baltimore 5
Not applicableUnknownNCT00861003
What this trial is testing

An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Korea University Guro Hospital 57
Not applicableLooking for participantsNCT07122531
What this trial is testing

Recovery With Exogenous Ketones and Antipsychotics

Who this might be right for
First Episode Psychosis
Université de Sherbrooke 15
Post-approval studies (Phase 4)Study completedNCT00306475
What this trial is testing

Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?

Who this might be right for
SchizophreniaSchizoaffective Disorder
Northwestern University 60
Not applicableStudy completedNCT00999895
What this trial is testing

A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients

Who this might be right for
Schizophrenia
AstraZeneca 574
Not applicableUnknownNCT04807634
What this trial is testing

Role of Intravenous Lipid Emulsion in Improving Coma of Acute Antipsychotics Poisoning

Who this might be right for
Coma
Ain Shams University 30
Post-approval studies (Phase 4)WithdrawnNCT02213887
What this trial is testing

Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications

Who this might be right for
Psychotic DisordersGastroesophageal Reflux
University of British Columbia
Testing effectiveness (Phase 2)Study completedNCT00073164
What this trial is testing

Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Abbott 400
Not applicableUnknownNCT01260116
What this trial is testing

Efficacy and Safety of Ziprasidone to Treat Depressive Symptoms in Patients With Schizophrenia

Who this might be right for
The Primary Evaluation is the Change From Baseline at End of Study for CDSS Total Scores.The Secondary Efficacy Evaluations Include: MADRS, PANSS Total Scores and Subscales and Responder Rate; CGI-S and CGI-I Scales.Safety Evaluations Include: Laboratory Test Abnormalities; BARS and SAS; Physical Examinations; Vital Signs; Electrocardiogram,Etc.+1 more
Wuhan University
Not applicableStudy completedNCT05172687
What this trial is testing

The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia

Who this might be right for
Alzheimer DiseaseDementiaPrescribing, Off-Label
Columbia University 336,460
Not applicableStudy completedNCT01222793
What this trial is testing

Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia

Who this might be right for
SchizophreniaObesity
National Institute on Drug Abuse (NIDA) 60
Early research (Phase 1)Study completedNCT00791284
What this trial is testing

The Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function

Who this might be right for
SchizophreniaHepatic Impairment
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20
Not applicableStudy completedNCT06787781
What this trial is testing

Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects

Who this might be right for
Metabolic EvaluationCardiac Complications
University of Messina 15
Large-scale testing (Phase 3)Ended earlyNCT00658645
What this trial is testing

Efficacy of Bifeprunox in Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 227
Next Page
120